News | June 03, 2026
Alkem launches single-shot Semaglutide pre-filled syringes at Rs. 350
DCGI-approved semaglutide syringes for diabetes and obesity expand treatment choices and improve affordability
DCGI-approved semaglutide syringes for diabetes and obesity expand treatment choices and improve affordability
_256_384.jpg)
HMD had supplied 921.7 million syringes to the Government of India to facilitate over 2.2 billion Vaccination in India till date
Quantitative restrictions in place to meet domestic needs to cater to the vaccination programme
New Shoolagiri plant strengthens Maiva’s global CDMO capabilities with advanced isolator technology, flexible production lines, and expanded capacity for complex injectable therapies
Consolidated entity plans to strengthen specialty pharmaceutical offerings, expand manufacturing capacity, and accelerate global market penetration across emerging regions
The newly commissioned facility strengthens the ’company’s capabilities in the development and manufacturing of generic and complex sterile injectable products
Teva said the launch strengthens its biosimilars strategy and expands access to biologic medicines across Europe
Combined company targets Rs. 2,500–3,000 crore revenue by 2030; new sterile and OSD plants to begin operations by August 2026
Early implementation of West Synchrony S1 platform aims to accelerate biologics and vaccine development while reducing manufacturing risk for biopharma partners
Once complete, the site will serve as AbbVie’s U.S. center of excellence for SVP manufacturing
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
